Community Mental Health Journal

, Volume 53, Issue 8, pp 936–950 | Cite as

Profile and Determinants of Disability in Psychotic Disorders in Nigeria

Original Paper

Abstract

We compared profile and predictors of disability among 210 patients with schizophrenia, schizoaffective disorder, bipolar I disorder with psychosis and depression with psychosis, respectively in a Nigerian clinical population, using the WHO Disability Assessment Schedule, (2.0). Severity of psychosis was determined with Positive and Negative Symptoms Scale, functioning was assessed using the Global Assessment of Functioning Scale, medication adherence with the Medication Adherence Questionnaire. Analyses were by SPSS 20.0. There were remarkable differences in the predictors of disability across these psychotic disorders. The findings strengthens the significance of psychosocial rehabilitation in patients with psychosis as clinical remission and medication adherence did not equate functional recovery.

Keywords

Schizophrenia Schizoaffective disorder Bipolar Disorder Depression Disability Community-rehabilitation 

Notes

Acknowledgements

We acknowledge all the members of our secretarial staff for their various supports.

Compliance with Ethical Standards

Conflict of interest

None.

References

  1. Adegbaju, D. A., Olagunju, A. T., & Uwakwe, R. (2013). A comparative analysis of disability in individuals with bipolar affective disorder and schizophrenia in a sub-Saharan African mental health hospital: Towards evidence-guided rehabilitation intervention. Social Psychiatry and Psychiatric Epidemiology, 6, 6.Google Scholar
  2. Adewuya, A., & Ola, A. (2008). Medication adherence in Nigerian patients with bipolar disorder. Schizophrenia Research, 98, 193–199.Google Scholar
  3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.Google Scholar
  4. Arvilommi, P., Suominen, K., Mantere, O., Valtonen, H., Leppamaki, S., & Isometsa, E. (2015). Predictors of long-term work disability among patients with type I and II bipolar disorder: A prospective 18-month follow-up study. Bipolar Disorders, 17(8), 821–835. doi: 10.1111/bdi.12349.CrossRefPubMedGoogle Scholar
  5. Bachrach, L. L. (2000). Psychosocial rehabilitation and psychiatry in the treatment of schizophrenia—what are the boundaries? Acta Psychiatrica Scandinavica 102(Suppl 407), 6–10.Google Scholar
  6. Bellack, A. S., Green, M. F., Cook, J. A., Fenton, W., Harvey, P. D., Heaton, R. K., Wykes, T. (2007). Assessment of community functioning in people with schizophrenia and other severe mental illnesses: A white paper based on an NIMH-sponsored workshop. Schizophrenia Bulletin, 33(3), 805–822. doi: 10.1093/schbul/sbl035.CrossRefPubMedGoogle Scholar
  7. Canuso, C. M., & Pandina, G. (2007). Gender and schizophrenia. Psychopharmacology Bulletin, 40(4), 178–190.PubMedGoogle Scholar
  8. Coker, A. O., Lasebikan, V. O., Olugbile, O. B., & Eaton, J. (2011). Psychiatric psychosocial rehabilitation in Nigeria; What needs to be done. Nigerian Journal of Psychiatry, 9(3), 2–9.Google Scholar
  9. Corrigan, P. W., McCracken, S. G., & Holmes, E. P. (2001). Motivational interviews as goal assessment for persons with psychiatric disability. Community Mental Health Journal, 37(2), 113–122.CrossRefPubMedGoogle Scholar
  10. Cousins, D. A., Butts, K., & Young, A. H. (2009). The role of dopamine in bipolar disorder. Bipolar Disorders, 11(8), 787–806. doi: 10.1111/j.1399-5618.2009.00760.x.CrossRefPubMedGoogle Scholar
  11. Crow, T. J. (1995). A continuum of psychosis, one human gene, and not much else—the case for homogeneity. Schizophrenia Research, 17(2), 135–145.CrossRefPubMedGoogle Scholar
  12. Dunlop, B. W., & Nemeroff, C. B. (2007). The role of dopamine in the pathophysiology of depression. Archives of General Psychiatry, 64(3), 327–337. doi: 10.1001/archpsyc.64.3.327.CrossRefPubMedGoogle Scholar
  13. Endicott, J., Spitzer, R. L., Fleiss, J. L., & Cohen, J. (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33(6), 766–771.CrossRefPubMedGoogle Scholar
  14. First, M., Spitzer, R., Gibbon, M., & Williams, J. (1996). Structured clinical interview for DSM-IV axis I disorders, clinical version (SCID-CV).. Washington, DC: American Psychiatric Press, Inc.Google Scholar
  15. Gade, K., Malzahn, D., Anderson-Schmidt, H., Strohmaier, J., Meier, S., Frank, J., Schulze, & T, G. (2015). Functional outcome in major psychiatric disorders and associated clinical and psychosocial variables: A potential cross-diagnostic phenotype for further genetic investigations? The World Journal Of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry, 16(4), 237–248. doi: 10.3109/15622975.2014.995221.CrossRefGoogle Scholar
  16. Green, M. F. (2006). Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. Journal of Clinical Psychiatry, 67(Suppl 9), 3–8 (discussion 36–42)PubMedGoogle Scholar
  17. Gureje, O. (2007). Psychiatry in Africa: The myths, the exotic, and the realities. South African Journal of Psychiatry, 10, 11–14.Google Scholar
  18. Gureje, O., Abdulmalik, J., Kola, L., Musa, E., Yasamy, M. T., & Adebayo, K. (2015). Integrating mental health into primary care in Nigeria: Report of a demonstration project using the mental health gap action programme intervention guide. BMC Health Services Research, 15, 242. doi: 10.1186/s12913-015-0911-3.CrossRefPubMedPubMedCentralGoogle Scholar
  19. Gureje, O., & Bamidele, R. (1999). Thirteen-year social outcome among Nigerian outpatients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 34(3), 147–151.CrossRefPubMedGoogle Scholar
  20. Gureje, O., Herrman, H., Harvey, C., Morgan, V., & Jablensky, A. (2002). The Australian National Survey of Psychotic Disorders: Profile of psychosocial disability and its risk factors. Psychological Medicine, 32(4), 639–647.CrossRefPubMedGoogle Scholar
  21. Gureje, O., & Lasebikan, V. (2006). Use of mental health services in a developing country. Results from the Nigerian survey of mental health and well-being. Social Psychiatry and Psychiatric Epidemiology, 41(1), 44–49.CrossRefPubMedGoogle Scholar
  22. Gureje, O., Lasebikan, V. O., Ephraim-Oluwanuga, O., Olley, B. O., & Kola, L. (2005). Community study of knowledge of and attitude to mental illness in Nigeria. The British Journal of Psychiatry, 186(5), 436–441. doi: 10.1192/bjp.186.5.436.CrossRefPubMedGoogle Scholar
  23. Hirschfeld, R. M., Calabrese, J. R., Frye, M. A., Lavori, P. W., Sachs, G., Thase, M. E., & Wagner, K. D. (2007). Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening. Psychopharmacology Bulletin, 40(3), 7–14.PubMedGoogle Scholar
  24. Holma, I. A., Holma, K. M., Melartin, T. K., Rytsala, H. J., & Isometsa, E. T. (2012). A 5-year prospective study of predictors for disability pension among patients with major depressive disorder. Acta Psychiatrica Scandinavica, 125(4), 325–334. doi: 10.1111/j.1600-0447.2011.01785.x.CrossRefPubMedGoogle Scholar
  25. Institute of Medicine Committee on Nervous System Disorders in Developing, C. (2001) Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the Developing World. Washington (DC): National Academies Press (US), Copyright 2001 by the National Academy of Sciences. All rights reserved.Google Scholar
  26. Kane, J. M., Carson, W. H., Saha, A. R., McQuade, R. D., Ingenito, G. G., Zimbroff, D. L., & Ali, M. W. (2002). Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. The Journal of Clinical Psychiatry, 63(9), 763–771.CrossRefPubMedGoogle Scholar
  27. Kigozi, F., & Kinyanda, E. (2006). Psychiatric rehabilitation today:An African perspective. World Psychiatry, 5(3), 166–166.PubMedPubMedCentralGoogle Scholar
  28. Lasebikan, V. O. (2016). Cultural aspects of mental health and mental health service delivery with a focus on Nigeria within a global community. Mental Health Religion Culture. doi: 10.1080/13674676.2016.1180672.Google Scholar
  29. Lasebikan, V. O., Owoaje, E. T., & Asuzu, M. C. (2012). Social network as a determinant of pathway to mental health service utilization among psychotic patients in a Nigerian hospital. Annals of African Medicine, 11(1), 12–20. doi: 10.4103/1596-3519.91010.CrossRefPubMedGoogle Scholar
  30. Lay, B., Blanz, B., Hartmann, M., & Schmidt, M. H. (2000). The psychosocial outcome of adolescent-onset schizophrenia: A 12-year followup. Schizophrenia Bulletin, 26(4), 801–816.CrossRefPubMedGoogle Scholar
  31. Lee, R. S., Hermens, D. F., Naismith, S. L., Lagopoulos, J., Jones, A., Scott, J., … Hickie (2015). Neuropsychological and functional outcomes in recent-onset major depression, bipolar disorder and schizophrenia-spectrum disorders: A longitudinal cohort study. Translational Psychiatry, 5, e555. doi: 10.1038/tp.2015.50.CrossRefPubMedPubMedCentralGoogle Scholar
  32. Leighton, A. H., Lambo, T. A., Hughes, C. C., et al. (1963). Psychiatric disorder among the Yoruba. Ithaca: Cornell University Press.Google Scholar
  33. Leucht, S., Arbter, D., Engel, R. R., Kissling, W., & Davis, J. M. (2009). How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Molecular Psychiatry, 14(4), 429–447. doi: 10.1038/sj.mp.4002136.CrossRefPubMedGoogle Scholar
  34. Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006). Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet, 367(9524), 1747–1757. doi: 10.1016/s0140-6736(06)68770-9.CrossRefPubMedGoogle Scholar
  35. Maier, W., Lichtermann, D., Minges, J., Hallmayer, J., Heun, R., Benkert, O., & Levinson, D. F. (1993). Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Archives of General Psychiatry, 50(11), 871–883.CrossRefPubMedGoogle Scholar
  36. Misdrahi, D., Petit, M., Blanc, O., Bayle, F., & Llorca, P. M. (2012). The influence of therapeutic alliance and insight on medication adherence in schizophrenia. Nordic Journal of Psychiatry, 66(1), 49–54. doi: 10.3109/08039488.2011.598556.CrossRefPubMedGoogle Scholar
  37. Mittendorfer-Rutz, E., Härkänen, T., Tiihonen, J., & Haukka, J. (2014). Association of Socio-Demographic Factors, Sick-Leave and Health Care Patterns with the Risk of Being Granted a Disability Pension among Psychiatric Outpatients with Depression. PLoS One, 9(6), e99869. doi: 10.1371/journal.pone.0099869.CrossRefPubMedPubMedCentralGoogle Scholar
  38. Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67–74.CrossRefPubMedGoogle Scholar
  39. Murray, C. J., & Lopez, A. D. (1997). Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet, 349(9064), 1498–1504. doi: 10.1016/s0140-6736(96)07492-2.CrossRefPubMedGoogle Scholar
  40. Murray, R. M., Sham, P., Van Os, J., Zanelli, J., Cannon, M., & McDonald, C. (2004). A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophrenia Research, 71(2–3), 405–416. doi: 10.1016/j.schres.2004.03.002.CrossRefPubMedGoogle Scholar
  41. Nguyen, D., & Bornheimer, L. A. (2014). Mental health service use types among Asian Americans with a psychiatric disorder: Considerations of culture and need. The Journal of Behavioral Health Services & Research, 41(4), 520–528. doi: 10.1007/s11414-013-9383-6.CrossRefGoogle Scholar
  42. Nil, R., Lutolf, S., & Seifritz, E. (2016). Residual symptoms and functionality in depressed outpatients: A one-year observational study in Switzerland with escitalopram. Journal of Affective Disorders, 197, 245–250. doi: 10.1016/j.jad.2016.02.062.CrossRefPubMedGoogle Scholar
  43. Novick, D., Montgomery, W., Treuer, T., Aguado, J., Kraemer, S., & Haro, J. M. (2015). Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: Results from a 1-year European outpatient observational study. BMC Psychiatry, 15, 189. doi: 10.1186/s12888-015-0560-4.CrossRefPubMedPubMedCentralGoogle Scholar
  44. Olsson, A. K., Hjarthag, F., & Helldin, L. (2016). Predicting real-world functional milestones in schizophrenia. Psychiatry Research, 242, 1–6. doi: 10.1016/j.psychres.2016.05.015.CrossRefPubMedGoogle Scholar
  45. Piccinelli, M., & Wilkinson, G. (2000). Gender differences in depression. Critical review. The British Journal of Psychiatry: The Journal of Mental Science, 177, 486–492.CrossRefGoogle Scholar
  46. Pinna, F., Deriu, L., Lepori, T., Maccioni, R., Milia, P., Sarritzu, E., … Carpiniello, B. (2013). Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders. Psychiatry Research, 210(3), 739–744. doi: 10.1016/j.psychres.2013.08.022.CrossRefPubMedGoogle Scholar
  47. RÖSsler, W. (2006). Psychiatric rehabilitation today: An overview. World Psychiatry, 5(3), 151–157.PubMedPubMedCentralGoogle Scholar
  48. Rytsala, H. J., Melartin, T. K., Leskela, U. S., Sokero, T. P., Lestela-Mielonen, P. S., & Isometsa, E. T. (2007). Predictors of long-term work disability in Major Depressive Disorder: A prospective study. Acta Psychiatrica Scandinavica, 115(3), 206–213. doi: 10.1111/j.1600-0447.2006.00878.x.CrossRefPubMedGoogle Scholar
  49. Schoeyen, H. K., Vaaler, A. E., Auestad, B. H., Malt, U. F., Melle, I., Andreassen, O. A., & Morken, G. (2011). Despite clinical differences, bipolar disorder patients from acute wards and outpatient clinics have similar educational and disability levels compared to the general population. Journal of Affective Disorders, 132(1–2), 209–215. doi: 10.1016/j.jad.2011.02.025.CrossRefPubMedGoogle Scholar
  50. Singh, M. M., & Kay, S. R. (1975). A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics. Psychopharmacologia, 43(2), 103–113.CrossRefPubMedGoogle Scholar
  51. Starling, J., Williams, L. M., Hainsworth, C., & Harris, A. W. (2013). The presentation of early-onset psychotic disorders. The Australian and New Zealand Journal of Psychiatry, 47(1), 43–50. doi: 10.1177/0004867412463615.CrossRefPubMedGoogle Scholar
  52. Stentebjerg-Olesen, M., Pagsberg, A. K., Fink-Jensen, A., Correll, C. U., & Jeppesen, P. (2016). Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review. Journal of Child and Adolescent Psychopharmacology. doi: 10.1089/cap.2015.0097.PubMedGoogle Scholar
  53. Szoke, A., Meary, A., Trandafir, A., Bellivier, F., Roy, I., Schurhoff, F., & Leboyer, M. (2008). Executive deficits in psychotic and bipolar disorders - implications for our understanding of schizoaffective disorder. European Psychiatry: The Journal of the Association of European Psychiatrists, 23(1), 20–25. doi: 10.1016/j.eurpsy.2007.10.006.CrossRefGoogle Scholar
  54. Tohen, M., Goldberg, J. F., Gonzalez-Pinto Arrillaga, A. M., Azorin, J. M., Vieta, E., Hardy-Bayle, M. C., … Breier, A (2003). A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Archives of General Psychiatry, 60(12), 1218–1226. doi: 10.1001/archpsyc.60.12.1218.CrossRefPubMedGoogle Scholar
  55. World Health Organization. (1994). The ICD-10 Classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines (10th ed.). Geneva: World Health Organization.Google Scholar
  56. Zimmerman, M., McGlinchey, J. B., Posternak, M. A., Friedman, M., Boerescu, D., & Attiullah, N. (2006). Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: Implications for how remission from depression should be defined. Psychiatry Research, 141(2), 185–191. doi: 10.1016/j.psychres.2005.05.016.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of Psychiatry, College of MedicineUniversity of IbadanIbadanNigeria
  2. 2.Department of PsychiatryUniversity College HospitalIbadanNigeria

Personalised recommendations